Lexicon Pharmaceuticals, Inc. (LXRX)
NasdaqGS - NasdaqGS 即時價格。貨幣為 USD。
加入追蹤清單
收市：04:00PM EDT
收市後：
| 前收市價 | 1.6300 |
| 開市 | 1.6300 |
| 買盤 | 1.6200 x 100 |
| 賣出價 | 1.6700 x 800 |
| 今日波幅 | 1.6050 - 1.6900 |
| 52 週波幅 | 0.9200 - 3.7900 |
| 成交量 | |
| 平均成交量 | 4,848,169 |
| 市值 | 406.291M |
| Beta 值 (5 年，每月) | 1.27 |
| 市盈率 (最近 12 個月) | 無 |
| 每股盈利 (最近 12 個月) | -0.8000 |
| 業績公佈日 | 2024年4月30日 - 2024年5月06日 |
| 遠期股息及收益率 | 無 (無) |
| 除息日 | 無 |
| 1 年預測目標價 | 5.50 |
ZacksAll You Need to Know About Lexicon (LXRX) Rating Upgrade to Buy
Lexicon (LXRX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
ZacksLexicon (LXRX) Dips on Post Hoc Analysis Data on Sotagliflozin
New post hoc analysis of data from Lexicon's (LXRX) phase III study shows improvements in glycemic control when treated with sotagliflozin for type 1 diabetes and chronic kidney disease.
ZacksLexicon Pharmaceuticals (LXRX) Reports Q4 Loss, Tops Revenue Estimates
Lexicon (LXRX) delivered earnings and revenue surprises of 13.04% and 3.24%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
